back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-06-15 13:58 Tx date 2023-06-08 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
$-752,155.39
-10,745,077 vol $0.07 each |
12,522,906 | |
| Filed 2023-06-15 13:49 Tx date 2023-06-08 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$752,155
+10,745,077 vol $0.07 each |
23,267,983 | |
| Filed 2023-06-15 13:41 Tx date 2023-06-08 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$752,155
+10,745,077 vol $0.07 each |
12,522,906 | |
| Filed 2023-01-25 23:44 Tx date 2023-01-24 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,725
+765,000 vol $0.065 each |
1,569,117 | |
| Filed 2023-01-25 23:32 Tx date 2023-01-24 |
$SZLS
StageZero Life Sciences Ltd. |
MacRae, Garth A. C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,725
+765,000 vol $0.065 each |
1,051,120 | |
| Filed 2023-01-25 23:29 Tx date 2023-01-24 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$91,455
+1,407,000 vol $0.065 each |
3,818,250 | |
| Filed 2023-01-25 23:27 Tx date 2023-01-24 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,725
+765,000 vol $0.065 each |
2,411,250 | |
| Filed 2023-01-25 23:22 Tx date 2023-01-24 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,725
+765,000 vol $0.065 each |
1,076,120 | |
| Filed 2022-10-21 13:27 Tx date 2022-10-20 |
$SZLS
StageZero Life Sciences Ltd. |
Riggs, Rory
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$411,000
+2,740,000 vol $0.15 each |
6,511,918 | |
| Filed 2021-09-03 18:51 Tx date 2021-09-02 |
$SZLS
StageZero Life Sciences Ltd. |
Health Clinics Limited
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,400,000 | ||
| Filed 2021-08-20 21:30 Tx date 2021-08-19 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,763
+28,300 vol $0.345 each |
261,059 | |
| Filed 2020-12-23 23:21 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,000
+100,000 vol $0.24 each |
232,759 | |
| Filed 2020-12-23 23:20 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Howard-Tripp, James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,000
-100,000 vol $0.24 each |
1,646,250 | |
| Filed 2020-12-23 23:18 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
MacRae, Garth A. C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,668
+36,120 vol $0.24 each |
147,086 | |
| Filed 2020-12-23 23:17 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
MacRae, Garth A. C.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,668.80
-36,120 vol $0.24 each |
286,120 | |
| Filed 2020-12-23 23:14 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,668
+36,120 vol $0.24 each |
107,154 | |
| Filed 2020-12-23 23:13 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,668.80
-36,120 vol $0.24 each |
311,120 | |
| Filed 2020-12-22 22:25 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Solomon, Carl
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-153,125 vol |
21,875 | |
| Filed 2020-12-22 22:09 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
MacRae, Garth A. C.
4 - Director of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-69,781 vol |
9,969 | |
| Filed 2020-12-22 22:08 Tx date 2020-12-15 |
$SZLS
StageZero Life Sciences Ltd. |
MacRae, Garth A. C.
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,255,680 vol |
322,240 |